Source comparison
TB-500 Studied Achilles Tendonitis: Full Comparison
TB-500 Peptide Therapy Upregulates actin polymerization, promotes angiogenesis, increases VEGF expression 2–4 weeks (case reports) Improved fiber alignment in animal models Animal studies + human case reports Strongest biological rationale, weakest human trial
This comparison does not assign a generated winner or score.
- TB-500 Peptide Therapy
- Upregulates actin polymerization, promotes angiogenesis, increases VEGF expression
- 2–4 weeks (case reports)
- Improved fiber alignment in animal models
- Animal studies + human case reports
- Strongest biological rationale, weakest human trial data. Promising but unproven in controlled human trials
- Eccentric Loading (Alfredson Protocol)
- Mechanical stimulus triggers collagen remodeling and increases tensile strength
- 6–12 weeks
- Proven in clinical trials to restore function
- Multiple RCTs, systematic reviews
- Gold standard conservative treatment. Evidence-based and widely replicated
- Platelet-Rich Plasma (PRP) Injection
- Growth factors from concentrated platelets stimulate repair
- 4–8 weeks
- Mixed results. Some studies show benefit, others show none
- Moderate (inconsistent trial results)
- Widely used but evidence is inconsistent; patient-specific factors likely determine efficacy
- Corticosteroid Injection
- Suppresses inflammation via glucocorticoid receptor activation
- 1–2 weeks (temporary)
- None. May weaken collagen long-term
- Strong evidence for short-term pain relief, concerns about structural integrity
- Fast symptom relief but does not promote healing. Risk of tendon weakening with repeated use
- NSAIDs (Oral Anti-Inflammatories)
- Inhibits COX enzymes to reduce prostaglandin-driven inflammation
- Days to 2 weeks
- None
- Strong for symptom management, not healing
- Symptom control only. Does not address underlying tendon pathology